摩德納公司
US ˙ NasdaqGS ˙ US60770K1079

SecurityMRNA / Moderna, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership4,845 shares
Latest Disclosed Value $ 133,673
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 11.92% increase in ownership of MRNA / Moderna, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 4,845 shares of Moderna, Inc. (US:MRNA) valued at $133,674 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 4,329 shares of Moderna, Inc.. This represents a change in shares of 11.92% during the quarter. The current value of the position is $249,954 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Moderna EC US60770K1079 4,845 516 11.92 134 9.02 1.4856
2025-05-29 2025-03-31 NP Moderna EC US60770K1079 4,329 276 6.81 123 -27.38 1.3038
2025-03-03 2024-12-31 NP Moderna EC US60770K1079 4,053 30 0.75 169 -37.31 1.6894
2024-11-29 2024-09-30 NP Moderna EC US60770K1079 4,023 1,543 62.22 269 -8.84 2.4352
2024-08-29 2024-06-30 NP Moderna EC US60770K1079 2,480 -957 -27.84 294 -19.67 2.6849
2024-05-30 2024-03-31 NP Moderna EC US60770K1079 3,437 -254 -6.88 366 -0.27 3.1060
2024-02-29 2023-12-31 NP Moderna EC US60770K1079 3,691 214 6.15 367 2.23 3.0085
2023-11-29 2023-09-30 NP Moderna EC US60770K1079 3,477 95 2.81 359 -12.44 3.1095
2023-08-28 2023-06-30 NP Moderna EC US60770K1079 3,382 295 9.56 411 -13.50 3.2427
2023-05-30 2023-03-31 NP Moderna EC US60770K1079 3,087 -722 -18.96 474 -30.70 3.5910
2023-02-28 2022-12-31 NP Moderna EC US60770K1079 3,809 -208 -5.18 684 44.00 4.1375
2022-11-29 2022-09-30 NP Moderna EC US60770K1079 4,017 -177 -4.22 475 -20.70 3.3149
2022-08-29 2022-06-30 NP Moderna EC US60770K1079 4,194 374 9.79 599 -8.97 4.1102
2022-05-26 2022-03-31 NP Moderna EC US60770K1079 3,820 66 1.76 658 -30.95 3.8884
2022-02-28 2021-12-31 NP Moderna EC US60770K1079 3,754 995 36.06 953 -10.18 4.2131
2021-11-29 2021-09-30 NP Moderna EC US60770K1079 2,759 -1,465 -34.68 1,062 6.96 4.4637
2021-08-27 2021-06-30 NP Moderna EC US60770K1079 4,224 -992 -19.02 993 45.24 4.1571
2021-05-27 2021-03-31 NP Moderna EC US60770K1079 5,216 -1,006 -16.17 683 5.08 3.0735
2021-03-01 2020-12-31 NP Moderna EC US60770K1079 6,222 -4,219 -40.41 650 -11.92 2.6472
2020-11-25 2020-09-30 NP Moderna EC US60770K1079 10,441 -55 -0.52 739 9.66 3.0831
2020-08-27 2020-06-30 NP Moderna EC US60770K1079 10,496 10,496 674 2.7160
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.